Source: Eur Respir J 2014; 44: 1557-1570
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Stolz Daiana, Meyer Anja, Rakic Janko, Boeck Lucas, Scherr Andreas, Tamm Michael. Mortality risk prediction in COPD by a prognostic biomarker panel. Eur Respir J 2014; 44: 1557-1570

Member's Comments

No comment yet.

Related content which might interest you: Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Pro-adrenomedullin is a predictive marker for all-cause mortality in stable COPD: An analysis of the COSYCONET study Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020 Risk factor biomarker differences in rehospitalization for patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 838s Year: 2006 Blood biomarker algorithms to guide COPD assessment and risk stratification Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Validation of bode index as a predictor of mortality in COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Mortality and prognostic factors in a cohort of COPD patients (EXACO study) Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016 Year: 2017 Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005 Analysis of NEWS2 trend to predict risk of death in COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis. Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD Source: Eur Respir J 2014; 43: 951-953 Year: 2014 Predictive factors of mortality in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 76s Year: 2007 Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Predictive modelling of COPD exacerbation rates using baseline risk factors Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020 Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017 Prognostic values of biomarkers in COPD Source: Annual Congress 2013 –Natural history of COPD: novel aspects Year: 2013 Pro-adrenomedullin as prognostic marker in patients with CAP Source: Annual Congress 2008 - Improved diagnosis and clinical decision-making by integrating information from new biomarkers Year: 2008